Journal Mobile Options
Table of Contents
Vol. 72, No. 1, 2004
Issue release date: January 2004
Section title: Original Paper
Urol Int 2004;72:28–31
(DOI:10.1159/000075269)

Squamous Cell Carcinoma of the Prostate

A Report of 6 Cases

Kanthan R. · Torkian B.
Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon, Sask., Canada

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 11/28/2002
Accepted: 5/21/2003
Published online: 1/20/2004

Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN

Abstract

Squamous cell carcinoma of the prostate is uncommon. In an attempt to assess the incidence of squamous cell carcinoma of the prostate, we searched the records of the Saskatchewan Cancer Agency over the past 30 years. Using strict diagnostic criteria a total of 6 cases of pure squamous cell carcinoma among 13,497 cases of prostatic carcinoma were identified. The ages of these patients ranged from 42 to 85 years. The survival rates of these cases ranged from 1 to 13 months.


  

Author Contacts

Dr. Rani Kanthan
Room 2868 ‘G’ Wing, Department of Pathology, Royal University Hospital
103, Hospital Drive, Saskatoon, Sask., S7N 0W8 (Canada)
Tel. +1 306 655 2158, Fax +1 306 655 2223
E-Mail rani.kanthan@saskatoonhealthregion.ca

  

Article Information

Received: November 28, 2002
Revised and accepted: May 19, 2003
Number of Print Pages : 4
Number of Figures : 1, Number of Tables : 1, Number of References : 9

  

Publication Details

Urologia Internationalis
Founded 1955 by G. Peter A. Narath and Heinrich Heusser; Continued 1968–1987 by G. Mayor

Vol. 72, No. 1, Year 2004 (Cover Date: Released January 2004)

Journal Editor: D. Hauri, Zürich; M. Porena, Perugia; M.P. Wirth, Dresden
ISSN: 0042–1138 (print), 1423–0399 (Online)

For additional information: http://www.karger.com/uin


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 11/28/2002
Accepted: 5/21/2003
Published online: 1/20/2004

Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.